Reduced cAMP, Akt activation and p65-c-Rel dimerization: Mechanisms involved in the protective effects of mGluR3 agonists in cultured astrocytes

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Durand, Daniela ^a   Carniglia, Lila ^a   Caruso, Carla ^a   Lasaga, Mercedes ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; DIMER; METABOTROPIC RECEPTOR 3; METABOTROPIC RECEPTOR AGONIST; PROTEIN KINASE B; TRANSCRIPTION FACTOR REL; TRANSCRIPTION FACTOR RELA; 4 AMINHO 2 THIABICYCLO(3.1.0)HEXANE 4,6 DICARBOXYLIC ACID; 4 AMINO 2 OXABICYCLO[3.1.0]HEXANE 4,6 DICARBOXYLIC ACID; 4-AMINHO-2-THIABICYCLO(3.1.0)HEXANE-4,6-DICARBOXYLIC ACID; AMINO ACID; FUSED HETEROCYCLIC RINGS; GLIAL FIBRILLARY ACIDIC PROTEIN; METABOTROPIC RECEPTOR; METABOTROPIC RECEPTOR 2; SULFOXIDE;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASTROCYTE; CELL CULTURE; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; DIMERIZATION; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; IMMUNOCYTOCHEMISTRY; IMMUNOPRECIPITATION; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; DRUG EFFECT; DRUG POTENTIATION; IMMUNOHISTOCHEMISTRY; METABOLISM; NEWBORN; NICK END LABELING; WESTERN BLOTTING;

RATTUS;

AMINO ACIDS; ANIMALS; ANIMALS, NEWBORN; ASTROCYTES; BICYCLO COMPOUNDS, HETEROCYCLIC; BLOTTING, WESTERN; CELLS, CULTURED; CYCLIC AMP; CYCLIC S-OXIDES; DIMERIZATION; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; IN SITU NICK-END LABELING; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-REL; RATS; RECEPTORS, METABOTROPIC GLUTAMATE; TRANSCRIPTION FACTOR RELA;

EID: 79960340621     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022235     Document Type: Article

References (49)

1. Benarroch EE, (2005) Neuron-astrocyte interactions: partnership for normal function and disease in the central nervous system. Mayo Clin Proc 80: 1326-1338.
2. Caruso C, Durand D, Schiöth HB, Rey R, Seilicovich A, et al. (2007) Activation of melanocortin 4 receptor reduces the inflammatory response and prevents apoptosis induced by lipopolisaccharide and interferon-gamma in astrocytes. Endocrinology 148: 4918-4926.
3. Durand D, Caruso C, Carniglia L, Lasaga M, (2010) Metabotropic glutamate receptor 3 activation prevents nitric oxide-induced death in cultured rat astrocytes. J Neurochem 112: 420-433.
4. Schoepp DD, Jane DE, Monn JA, (1999) Pharmacological agents acting at subtypes of metabotropic glutamate receptors. Neuropharmacology 38: 1431-76.
5. Mudo G, Trovato-Salinaro A, Caniglia G, Cheng Q, Condorelli DF, (2007) Cellular localization of mGluR3 and mGluR5 mRNAs in normal and injured rat brain. Brain Res 1149: 1-13.
6. Kingston AE, O'Neill MJ, Lam A, Bales KR, Monn JA, et al. (1999) Neuroprotection by metabotropic glutamate receptor agonists: LY354740, LY379268 and LY389795. Eur J Pharmacol 377: 155-165.
7. Bruno V, Battaglia G, Casabona G, Copani A, Caciagli F, et al. (1998) Neuroprotection by glial metabotropic glutamate receptor is mediated by transforming growth factor-beta. J Neurosci 18: 9594-9600.
8. Ciccarelli R, D'Alimonte I, Ballerini P, D'Auro M, Nargi E, et al. (2007) Molecular signaling mediating the protective effect of A1 adenosine and mGluR3 metabotropic glutamate receptor activation against apoptosis by oxygen/glucose deprivation in cultured astrocytes. Mol Pharmacol 71: 1369-1380.
9. Sarnico I, Boroni F, Benarese M, Sigala S, Lanzillotta A, et al. (2008) Activation of NF-κB p65/c-Rel dimer is associated with neuroprotection elicited by mGlu5 receptor agonists against MPP+ toxicity in SK-N-SH cells. J Neural Transm 115: 669-676.
10. D'Onofrio M, Cuomo L, Battaglia G, Ngomba RT, Storto M, et al. (2001) Neuroprotection mediated by glial group-II metabotropic glutamate receptors requires the activation of the MAP kinase and the phosphatidylinositol-3-kinase pathways. J Neurochem 78: 435-445.
11. Di Iorio P, Ballerini P, Traversa U, Nicoletti F, D'Alimonte I, et al. (2004) The anti-apoptotic effect of guanosine is mediated by the activation of the PI3-kinase/Akt/PKB pathway in cultured rat astrocytes. Glia 46: 356-368.
12. Dudek H, Datta SR, Franke TF, Birnbaum MJ, Yao R, et al. (1997) Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science (Wash DC) 275: 661-665.
13. Caruso C, Mohn C, Karara AL, Rettori V, Watanobe H, et al. (2004) Alpha-melanocyte-stimulating hormone through melanocortin-4 receptor inhibits nitric oxide synthase and cyclooxygenase expression in the hypothalamus of male rats. Neuroendocrinology 79: 278-86.
14. Condorelli DF, Dell'Albani P, Corsaro M, Giuffrida R, Caruso A, et al. (1997) Metabotropic glutamate receptor expression in cultured rat astrocytes and human gliomas. Neurochem Res 22: 1127-1133.
15. Ferraguti F, Corti C, Valerio E, Mion S, Xuereb J, (2001) Activated astrocytes in areas of kainate-induced neuronal injury upregulate the expression of the metabotropic glutamate receptors 2/3 and 5. Exp Brain Res 137: 1-11.
16. Ohishi H, Shigemoto R, Nakanishi S, Mizuno N, (1993a) Distribution of the messenger RNA for a metabotropic glutamate receptor, mGluR2, in the central nervous system of the rat. Neuroscience 53: 1009-1018.
17. Ohishi H, Shigemoto R, Nakanishi S, Mizuno N, (1993b) Distribution of the mRNA for a metabotropic glutamate receptor (mGluR3) in the rat brain: an in situ hybridization study. J Comp Neurol 335: 252-266.
18. Schools GP, Kimelberg HK, (1999) mGluR3 and mGluR5 are the predominant metabotropic glutamate receptor mRNAs expressed in hippocampal astrocytes acutely isolated from young rats. J Neurosci Res 58: 533-543.
19. Wroblewska B, Santi MR, Neale JH, (1998) N-Acetylaspartylglutamate activates cyclic AMP-coupled metabotropic glutamate receptors in cerebellar astrocytes. Glia 24: 172-179.
20. Ciccarelli R, Sureda FX, Casabona G, Di Iorio P, Caruso A, et al. (1997) Opposite influence of the metabotropic glutamate receptor subtypes mGlu3 and-5 on astrocyte proliferation in culture. Glia 21: 390-398.
21. Janssens N, Lesage ASJ, (2001) Glutamate receptor subunit expression in primary neuronal and secondary glial cultures. J Neurochem 77: 1457-1474.
22. Monn JA, Matthew JV, Massey SM, Hansen MM, Kress TJ, et al. (1999) Synthesis, pharmacological characterization, and molecular modeling of heterobicyclic amino acids related to (+)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY354740): identification of two new potent, selective, and systemically active agonists for group II metabotropic glutamate receptors. J Med Chem 42: 1027-1040.
23. Rorick-Kehn LM, Johnson BG, Burkey JL, Wright RA, Calligaro DO, et al. (2007) Pharmacological and pharmacokinetic properties of a structurally novel, potent, and selective metabotropic glutamate 2/3 receptor agonist: in vitro characterization of agonist (-)-(1R,4S,5S,6S)-4-amino-2-sulfonylbicyclo[3.1.0]-hexane-4,6-dicarboxylic acid (LY404039). J Pharmacol Exp Ther 321: 308-317.
24. Pizzi M, Sarnico I, Boroni F, Benarese M, Steimberg N, et al. (2005) NF-κB factor c-Rel mediates neuroprotection elicited by mGlu5 receptor agonists against amyloid β-peptide toxicity. Cell Death Differ 12: 761-772.
25. Sarnico I, Lanzillotta A, Boroni F, Benarese M, Alghisi M, et al. (2009) NF-κB p50/RelA and c-Rel-containing dimmers: opposite regulators of neuron vulnerability to ischaemia. J Neurochem 108: 475-485.
26. Thomas DD, Ridnour LA, Isenberg JS, Flores-Santana W, Switzer CH, et al. (2008) The Chemical Biology of Nitric Oxide. Implications in Cellular Signaling. Free Radic Biol Med 45: 18-31.
27. Wroblewska B, Wegorzewska I, Bzdega T, Olszewski R, Neal J, (2006) Differential negative coupling of type 3 metabotropic glutamate receptor to cyclic GMP levels in neurons and astrocytes. J Neurochem 96: 1071-1077.
28. Zhao Z, Leister WH, Robinson RG, Barnett SF, Defeo-Jones D, et al. (2005) Discovery of 2,3,5-trisubstituted pyridine derivatives as potent Akt1 and Akt2 dual inhibitors. Bioorganic & Medicinal Chemistry Letters 15: 905-909.
29. Bhattacharyya J, Biswas S, Datta AG, (2004) Mode of action of endotoxin: role of free radicals and antioxidants. Curr Med Chem 11: 359-368.
30. Kozuka N, Kudo Y, Morita M, (2007) Multiple inhibitory pathways for lipopolisaccharide- and pro-inflammatory cytokine-induced nitric oxide production in cultured astrocytes. Neuroscience 144: 911-919.
31. Murphy S, Lin HL, Park SK, (1995) Cytokine-induced expression of type II nitric oxide synthase in astrocytes is downregulated by ATP and glutamate. Glia 15: 77-82.
32. Weil R, Whiteside ST, Israël A, (1997) Control of NF-kappa B activity by the I kappa B beta inhibitor. Immunobiology 198: 14-23.
33. Thompson JE, Phillips RJ, Erdjument-Bromage H, Tempst P, Ghosh S, (1995) I kappa B-beta regulates the persistent response in a biphasic activation of NFkappaB. Cell 80: 573-582.
34. Nasuhara Y, Adcock IM, Catley M, Barnes PJ, Newton R, (1999) Differential IκB kinase activation and IκBα degradation by interleukin-1β and tumor necrosis factor-α in human U937 monocytic cells. J Biol Chem 274: 19965-19972.
35. Pizzi M, Goffi F, Boroni F, Benarese M, Perkins SE, et al. (2002) Opposing roles for NF-kappa B/Rel factors p65 and c-Rel in the modulation of neuron survival elicited by glutamate and interleukin-1beta. J Biol Chem 277: 20717-20723.
36. Kögel D, Peters M, König HG, Hashemi SM, Bui NT, et al. (2004) S100B potently activates p65/c-Rel transcriptional complexes in hippocampal neurons: clinical implications for the role of S100B in excitotoxic brain injury. Neuroscience 127: 913-920.
37. Valerio A, Dossena M, Bertolotti P, Boroni F, Sarnico I, et al. (2009) Leptin is induced in the ischemic cerebral cortex and exerts neuroprotection through NF-κB/c-Rel-dependent transcription. Stroke 40: 610-617.
38. Giri S, Rattan R, Singh AK, Singh I, (2004) The 15-deoxy-delta12,14-prostaglandin J2 inhibits the inflammatory response in primary rat astrocytes via down-regulating multiple steps in phosphatidylinositol 3-kinase-Akt-NF-kappaB-p300 pathway independent of peroxisome proliferator-activated receptor gamma. J Immunol 173: 5196-5208.
39. Faden AI, Ivanova SA, Yakovlev AG, Mukhin AG, (1997) Neuroprotective effects of group III mGluR in traumatic neuronal injury. J Neurotrauma 14: 885-895.
40. Srivastava RK, Srivastava AR, Korsmeyer SJ, Nesterova M, Cho-Chung YS, et al. (1998) Involvement of microtubules in the regulation of Bcl2 phosphorylation and apoptosis through cyclic AMP-dependent protein kinase. Mol Cell Biol 18: 3509-3517.
41. Kim S, Jee K, Kim D, Koh H, Chung J, (2001) Cyclic AMP inhibits Akt activity by blocking the membrane localization of PDK1. J Biol Chem 276: 12864-12870.
42. Sumbayev VV, Yasinska IM, (2005) Regulation of MAP kianse-dependent apoptotic pathway: implication of reactive oxygen and nitrogen species. Arch Biochem Biophys 436: 406-412.
43. Peng XQ, Damarla M, Skirball J, Nonas S, Wang XY, et al. (2010) Protective role of PI3-kinase/Akt/eNOS signaling in mechanical stress through inhibition of p38 mitogen-activated protein kinase in mouse lung. Acta Pharmacol Sin 31: 175-183.
44. Wang Y, Wang S, Wier WG, Zhang Q, Jiang H, et al. (2010) Exercise improves the dilatation function of mesenteric arteries in postmyocardial infarction rats via a PI3K/Akt/eNOS pathway-mediated mechanism. Am J Physiol Heart Circ Physiol 299: 097-106.
45. Yoo K, Choi JW, Choi MS, Ryu MK, Park GH, et al. (2005) Mitogen-activated protein kinases (MAPKs) mediate SIN-1/glucose deprivation-induced death in rat primary astrocytes. Arch Pharm Res 28: 942-947.
46. Fernandes A, Falcao AS, Silva RF, Brito MA, Brites D, (2007) MAPKs are key players in mediating cytokine release and cell death induced by unconjugated bilirubin in cultured rat cortical astrocytes. Eur J Neurosci 25: 1058-1068.
47. Chen SH, Lin JK, Liu SH, Liang YC, Lin-Shiau SY, (2008) Apoptosis of cultured astrocytes induced by the copper and neocuproine complex through oxidative stress and JNK activation. Toxicol Sci 102: 138-149.
48. Perez V, Bouschet T, Fernandez C, Bockaert J, Journot L, (2005) Dynamic reorganization of the astrocyte actin cytoskeleton elicited by cAMP and PACAP: a role for phosphatidylinositol 3-kinase inhibition. Eur J Neurosci 21: 26-32.
49. Salminen A, Kaarniranta K, (2010) Insulin/IGF-1 paradox of aging: regulation via AKT/IKK/NF-kappaB signaling. Cell Signal 22: 573-577.